1,025
Views
19
CrossRef citations to date
0
Altmetric
Review Article

Unsolved challenges in pediatric whole-exome sequencing: A literature analysis

, , &
Pages 134-142 | Received 13 Sep 2016, Accepted 19 Dec 2016, Published online: 28 Jan 2017

References

  • Koboldt DC, Steinberg KM, Larson DE, et al. The next-generation sequencing revolution and its impact on genomics. Cell 2013;155:27–38
  • Thevenon J, Duffourd Y, Masurel-Paulet A, et al. Diagnostic odyssey in severe neurodevelopmental disorders: towards clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet 2016;89:700–7
  • Levenson D. Whole-exome sequencing emerges as clinical diagnostic tool. Am J Med Genet Part A 2014;164:ix. doi: 10.1002/ajmg.a.36385
  • van Zelst-Stams WA, Scheffer H, Veltman JA. Clinical exome sequencing in daily practice: 1,000 patients and beyond. Genome Med 2014;6:2. eCollection 2014. doi:10.1186/gm521
  • Jacob HJ, Abrams K, Bick DP, et al. Genomics in clinical practice: lessons from the front lines. Sci Transl Med 2013;5:194cm5. doi: 10.1126/scitranslmed.3006468
  • Wade CH, Tarini BA, Wilfond BS. Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice. Annu Rev Genomics Hum Genet 2013;14:535–55
  • Bertier G, Hétu M, Joly Y. Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users’ views. BMC Med Genomics 2016;9:52. doi:10.1186/s12920-016-0213-6
  • Botkin JR, Belmont JW, Berg JS, et al. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 2015;97:6–21
  • American Academy of Pediatrics. Ethical and policy issues in genetic testing and screening of children. Pediatrics 2013;131:620–2
  • Knobloch K, Yoon U, Vogt PM. Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 2011;39:91–2
  • Petticrew M, Roberts H. Systematic Reviews in the Social Sciences: A Practical Guide. Oxford, UK: Blackwell Publishing; 2006:1–336
  • Downe-Wamboldt B. Content analysis: method, applications, and issues. Health Care Women Int 1992;13:313–21
  • Katsanis SH, Katsanis N. Molecular genetic testing and the future of clinical genomics. Nat Rev Genet 2013;14:415–26
  • Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med 2014;370:2418–25
  • Merrill SL, Vaidya A, Pyeritz RE. Ethical challenges of the use of whole exome sequencing in the clinic. World J Pediatr Congenit Hear Surg 2013;4:58–61
  • Jiang Y-H, Wang Y, Xiu X, et al. Genetic diagnosis of autism spectrum disorders: the opportunity and challenge in the genomics era. Crit Rev Clin Lab Sci 2014;51:249–62
  • Russell M, Roberts AE, Abrams DJ, et al. How to effectively utilize genetic testing in the care of children with cardiomyopathies. Prog Pediatr Cardiol 2015;39:3–11
  • Sayson B, Popurs MAM, Lafek M, et al. Retrospective analysis supports algorithm as efficient diagnostic approach to treatable intellectual developmental disabilities. Mol Genet Metab 2015;115:1–9
  • Carss KJ, Hillman SC, Parthiban V, et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 2014;23:3269–77
  • Boycott KM, Vanstone MR, Bulman DE, et al. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat Rev Genet 2013;14:681–91
  • Sastre L. Exome sequencing: what clinicians need to know. Adv Genomics Genet 2014;4:15–27
  • Soden SE, Saunders CJ, Willig LK, et al. Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders. Sci Transl Med 2014;6:265ra168. doi:10.1126/scitranslmed.3010076
  • Lazaridis KN, Schahl KA, Cousin MA, et al. Outcome of whole exome sequencing for diagnostic odyssey cases of an individualized medicine clinic. Mayo Clin Proc 2016;91:297–307
  • Tetreault M, Bareke E, Nadaf J, et al. Whole-exome sequencing as a diagnostic tool: current challenges and future opportunities. Exp Rev Mol Diagn 2015;15:749–60
  • Huser V, Sincan M, Cimino JJ. Developing genomic knowledge bases and databases to support clinical management: current perspectives. Pharmgenomics Pers Med 2014;7:275–83
  • Marian AJ. Sequencing your genome: what does it mean? Methodist Debakey Cardiovasc J 2014;10:3–6
  • Beckmann JS. Can we afford to sequence every newborn baby’s genome?. Hum Mutat 2015;36:283–6
  • Iacobazzi V, Infantino V, Castegna A, et al. Hyperhomocysteinemia: related genetic diseases and congenital defects, abnormal DNA methylation and newborn screening issues. Mol Genet Metab 2014;113:27–33
  • Glade Bender J, Verma A, Schiffman JD. Translating genomic discoveries to the clinic in pediatric oncology. Curr Opin Pediatr 2015;27:34–43
  • Ream MA, Mikati MA. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav 2014;37:241–8
  • Grody WW, Thompson BH, Hudgins L. Whole-exome/genome sequencing and genomics. Pediatrics 2013;132:S211–15
  • Shashi V, McConkie-Rosell A, Schoch K, et al. Practical considerations in the clinical application of whole-exome sequencing. Clin Genet 2016;89:173–181
  • Vora NL, OʼBrien BM. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies. Obstet Gynecol 2014;123:1097–9
  • Klein H-G, Bauer P, Hambuch T. Whole genome sequencing (WGS), whole exome sequencing (WES) and clinical exome sequencing (CES) in patient care. LaboratoriumsMedizin 2014;38:221–30
  • Babkina N, Graham JM. New genetic testing in prenatal diagnosis. Semin Fetal Neonatal Med 2014;19:214–19
  • Atwal PS, Brennan M-L, Cox R, et al. Clinical whole-exome sequencing: are we there yet?. Genet Med 2014;16:717–19
  • O’Donnell-Luria AH, Miller DT. A clinician’s perspective on clinical exome sequencing. Hum Genet 2016;135:643–54
  • Lohmann K, Klein C. Next generation sequencing and the future of genetic diagnosis. Neurotherapeutics 2014;11:699–707
  • Bertier G, Carrot-Zhang J, Ragoussis V, et al. Integrating precision cancer medicine into healthcare—policy, practice, and research challenges. Genome Med 2016;8:108. doi:10.1186/s13073-016-0362-4
  • Neveling K, Feenstra I, Gilissen C, et al. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases. Hum Mutat 2013;34:1721–6
  • Rabbani B, Tekin M, Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet 2014;59:5–15
  • Newman W, Black G. Delivery of a clinical genomics service. Genes (Basel) 2014;5:1001–17
  • Arboleda V, Lee H, Sánchez F, et al. Targeted massively parallel sequencing provides comprehensive genetic diagnosis for patients with disorders of sex development. Clin Genet 2013;83:35–43
  • Vasta V, Merritt IIJL, Saneto RP, et al. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum. Pediatr Int 2012;54:585–601
  • Holtzman NA. Predictive genetic testing: from basic research to clinical practice. Science (80-.) 1997;278:602–605
  • Berg JS. Genome-scale sequencing in clinical care. JAMA 2014;312:1865–7
  • Biesecker LG, Biesecker BB. An approach to pediatric exome and genome sequencing. Curr Opin Pediatr 2014;26:639–45
  • Gonzalez-Garay ML, McGuire AL, Pereira S, et al. Personalized genomic disease risk of volunteers. Proc Natl Acad Sci U S A 2013;110:16957–62
  • Gomez-Lobo V. Multidisciplinary care for individuals with disorders of sex development. Curr Opin Obstet Gynecol 2014;26:366–71
  • Bennett NC, Farah CS. Next-generation sequencing in clinical oncology: next steps towards clinical validation. Cancers (Basel) 2014;6:2296–312
  • ACMG Board of Directors. Points to consider in the clinical application of genomic sequencing. Genet Med 2012;14:759–61
  • ACMG Board of Directors. Points to consider for informed consent for genome/exome sequencing. Genet Med 2013;15:748–9
  • ACMG Board of Directors. ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing. Genet Med 2014;17:68–9
  • van El CG, Cornel MC, Borry P, et al. Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet 2013;21:580–4
  • Matthijs G, Souche E, Alders M, et al. Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 2016;24:2–5
  • Boycott K, Hartley T, Adam S, et al. The clinical application of genome-wide sequencing for monogenic diseases in Canada: Position Statement of the Canadian College of Medical Geneticists. J Med Genet 2015;52:431–7
  • Amendola LM, Jarvik GP, Leo MC, et al. Performance of ACMG-AMP variant-interpretation guidelines among nine laboratories in the Clinical Sequencing Exploratory Research Consortium. Am J Hum Genet 2016;98:1067–76
  • Gargis AS, Kalman L, Bick DP, et al. Good laboratory practice for clinical next-generation sequencing informatics pipelines. Nat Biotechnol 2015;33:689–93
  • Miller NA, Farrow EG, Gibson M, et al. A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases. Genome Med 2015;7:100. doi: 10.1186/s13073-015-0221-8
  • Warr A, Robert C, Hume D, et al. Exome sequencing: current and future perspectives. G3- Genes|Genomes|Genetics 2015;5:1543–50
  • Aziz N, Zhao Q, Bry L, et al. College of American Pathologists’ laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 2015;139:481–93
  • Rehm HL, Bale SJ, Bayrak-Toydemir P, et al. ACMG clinical laboratory standards for next-generation sequencing. Genet Med 2013;15:733–47
  • Sénécal K, Vears DF, Bertier G, et al. Genome-based newborn screening: a conceptual analysis of the best interests of the child standard. Per Med 2015;12:439–41
  • Bredenoord AL, de Vries MC, van Delden JJM. Next-generation sequencing: does the next generation still have a right to an open future?. Nat Rev Genet 2013;14:306
  • Feinberg J, The child’s right to an open future. In: Aiken W, LaFollette H, eds. Whose Child? Child Rights, Parent Authority, and State Power. Totowa, NJ: Rowman Littlefield, 1980:124–53
  • Rahimzadeh V, Avard D, Sénécal K, et al. To disclose, or not to disclose? Context matters. Eur J Hum Genet 2015;23:279–84
  • Philippakis AA, Azzariti DR, Beltran S, et al. The Matchmaker exchange: a platform for rare disease gene discovery. Hum Mutat 2015;36:915–21
  • The Global Alliance for Genomics and Health, Coste B, Davies H, et al. A federated ecosystem for sharing genomic, clinical data. Science (80-.) 2016;352:1278–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.